Close Menu

Senator Benjamin Cardin (D–Md.) introduced a bill that would have NIH spend more of its stimulus funds on small businesses that are commercializing research, reports ScienceInsider. In the American Recovery and Reinvestment Act, NIH was exempt from the 2.8 percent “tax” that other agencies pay to fund the Small Business Innovation Research programs. This bill would have NIH contribute $150 million of its stimulus money on SBIR grants.Fo

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.